Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors

Tobias Schifter, John M. Hoffman, Michael W. Hanson, Orest Boyko, Craig Beam, Susan Paine, S. Clifford Schold, Peter C. Burger, R. Edward Coleman

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Objective: This study examines the changes in tumor [18F]fluoro-2- deoxyglucose (FDG) uptake on serial FDG-PET studies and the ability of serial FDG-PET studies to predict survival in patients with treated and untreated primary brain tumors. Materials and Methods: The study population included 20 patients with primary brain tumors. Changes in FDG uptake over time were visually assessed and correlated with clinical course and survival. Results: Although little change in FDG uptake was noted for individual patients, high average FDG uptake (greater than or equal to gray matter) on serial studies was associated with shorter survival. Patients with persistently low FDG uptake (less than gray matter) survived significantly longer than patients with persistently high FDG uptake (p = 0.007). Conclusion: Serial evaluation of metabolic activity with PET may provide more accurate prognostic information than a single FDG uptake determination in patients with primary brain tumors.

Original languageEnglish (US)
Pages (from-to)509-516
Number of pages8
JournalJournal of Computer Assisted Tomography
Volume17
Issue number4
StatePublished - 1993
Externally publishedYes

Fingerprint

Pets
Deoxyglucose
Brain Neoplasms
Survival

Keywords

  • Brain
  • Emission computed tomography
  • Fluorodeoxy glucose
  • Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Schifter, T., Hoffman, J. M., Hanson, M. W., Boyko, O., Beam, C., Paine, S., ... Coleman, R. E. (1993). Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors. Journal of Computer Assisted Tomography, 17(4), 509-516.

Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors. / Schifter, Tobias; Hoffman, John M.; Hanson, Michael W.; Boyko, Orest; Beam, Craig; Paine, Susan; Schold, S. Clifford; Burger, Peter C.; Coleman, R. Edward.

In: Journal of Computer Assisted Tomography, Vol. 17, No. 4, 1993, p. 509-516.

Research output: Contribution to journalArticle

Schifter, T, Hoffman, JM, Hanson, MW, Boyko, O, Beam, C, Paine, S, Schold, SC, Burger, PC & Coleman, RE 1993, 'Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors', Journal of Computer Assisted Tomography, vol. 17, no. 4, pp. 509-516.
Schifter T, Hoffman JM, Hanson MW, Boyko O, Beam C, Paine S et al. Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors. Journal of Computer Assisted Tomography. 1993;17(4):509-516.
Schifter, Tobias ; Hoffman, John M. ; Hanson, Michael W. ; Boyko, Orest ; Beam, Craig ; Paine, Susan ; Schold, S. Clifford ; Burger, Peter C. ; Coleman, R. Edward. / Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors. In: Journal of Computer Assisted Tomography. 1993 ; Vol. 17, No. 4. pp. 509-516.
@article{d4cd2b95a1fb475b8963751956facd7d,
title = "Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors",
abstract = "Objective: This study examines the changes in tumor [18F]fluoro-2- deoxyglucose (FDG) uptake on serial FDG-PET studies and the ability of serial FDG-PET studies to predict survival in patients with treated and untreated primary brain tumors. Materials and Methods: The study population included 20 patients with primary brain tumors. Changes in FDG uptake over time were visually assessed and correlated with clinical course and survival. Results: Although little change in FDG uptake was noted for individual patients, high average FDG uptake (greater than or equal to gray matter) on serial studies was associated with shorter survival. Patients with persistently low FDG uptake (less than gray matter) survived significantly longer than patients with persistently high FDG uptake (p = 0.007). Conclusion: Serial evaluation of metabolic activity with PET may provide more accurate prognostic information than a single FDG uptake determination in patients with primary brain tumors.",
keywords = "Brain, Emission computed tomography, Fluorodeoxy glucose, Neoplasms",
author = "Tobias Schifter and Hoffman, {John M.} and Hanson, {Michael W.} and Orest Boyko and Craig Beam and Susan Paine and Schold, {S. Clifford} and Burger, {Peter C.} and Coleman, {R. Edward}",
year = "1993",
language = "English (US)",
volume = "17",
pages = "509--516",
journal = "Journal of Computer Assisted Tomography",
issn = "0363-8715",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Serial fdg-pet studies in the prediction of survival in patients with primary brain tumors

AU - Schifter, Tobias

AU - Hoffman, John M.

AU - Hanson, Michael W.

AU - Boyko, Orest

AU - Beam, Craig

AU - Paine, Susan

AU - Schold, S. Clifford

AU - Burger, Peter C.

AU - Coleman, R. Edward

PY - 1993

Y1 - 1993

N2 - Objective: This study examines the changes in tumor [18F]fluoro-2- deoxyglucose (FDG) uptake on serial FDG-PET studies and the ability of serial FDG-PET studies to predict survival in patients with treated and untreated primary brain tumors. Materials and Methods: The study population included 20 patients with primary brain tumors. Changes in FDG uptake over time were visually assessed and correlated with clinical course and survival. Results: Although little change in FDG uptake was noted for individual patients, high average FDG uptake (greater than or equal to gray matter) on serial studies was associated with shorter survival. Patients with persistently low FDG uptake (less than gray matter) survived significantly longer than patients with persistently high FDG uptake (p = 0.007). Conclusion: Serial evaluation of metabolic activity with PET may provide more accurate prognostic information than a single FDG uptake determination in patients with primary brain tumors.

AB - Objective: This study examines the changes in tumor [18F]fluoro-2- deoxyglucose (FDG) uptake on serial FDG-PET studies and the ability of serial FDG-PET studies to predict survival in patients with treated and untreated primary brain tumors. Materials and Methods: The study population included 20 patients with primary brain tumors. Changes in FDG uptake over time were visually assessed and correlated with clinical course and survival. Results: Although little change in FDG uptake was noted for individual patients, high average FDG uptake (greater than or equal to gray matter) on serial studies was associated with shorter survival. Patients with persistently low FDG uptake (less than gray matter) survived significantly longer than patients with persistently high FDG uptake (p = 0.007). Conclusion: Serial evaluation of metabolic activity with PET may provide more accurate prognostic information than a single FDG uptake determination in patients with primary brain tumors.

KW - Brain

KW - Emission computed tomography

KW - Fluorodeoxy glucose

KW - Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0027181786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027181786&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 509

EP - 516

JO - Journal of Computer Assisted Tomography

JF - Journal of Computer Assisted Tomography

SN - 0363-8715

IS - 4

ER -